A proposed clinical workflow aims to mitigate the risk of lead-related superior vena cava syndrome, a complication responsible for roughly 30% of all SVC syndrome cases.
In this viewpoint, after an overview of the background of lead-related superior vena cava (SVC) syndrome, we propose a structured clinical workflow intended to reduce the risk of lead-related SVC syndrome. Superior vena cava (SVC) syndrome is a rare condition of stenosis of the SVC resulting in symptoms. In the majority of 60% of the patients, SVC syndrome is caused by a malignancy. However, in approximately 30% of all the patients with SVC syndrome, it is related to cardiac implantable electronic device (CIED) leads and central venous catheters (CVC).
Daniëls et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: